Stock AnalizDiversified Healthcare Trust DHC
Real Estate Investment Trusts · data as of November 13, 2026
Diversified Healthcare Trust (DHC) is a real estate company listed in the US with a market value of about $1.8B. In the twelve months to September 30, 2026 it had revenue of $1.5B and net income of -$152M, a net margin of -10.3%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of -1% a year, a 5-year average ROIC of -2%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 72% below the current price.
Score: 0.8 / 5
Checks passed
- Profit margin improving
- Pays a dividend
- Dividend 3 years in a row
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.5B | $1.4B | $1.3B | $1.4B | $1.6B | $1.0B | $1.1B | $1.1B | $1.1B |
| Net income | -$152M | -$286M | -$370M | -$294M | -$16M | $175M | -$139M | -$88M | $287M | $148M | $141M |
| Free cash flow | -$65M | -$166M | -$89M | -$225M | -$340M | -$291M | -$27M | $43M | $289M | $302M | $325M |
| EPS (diluted) | $-0.64 | $-1.19 | $-1.55 | $-1.23 | $-0.07 | $0.73 | $-0.59 | $-0.37 | $1.21 | $0.62 | $0.60 |
| Net margin | -10.3% | -18.6% | -24.8% | -20.8% | -1.2% | 12.6% | -8.5% | -8.5% | 25.7% | 13.7% | 13.4% |
| ROIC | — | -3.9% | -2.0% | -3.5% | -1.5% | -0.6% | -0.2% | 1.7% | 3.4% | 5.7% | 6.1% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 4 analysts is $9.88, 37% above the current price; targets range from $8.00 to $11.00; the consensus rating is “Buy”; expected EPS is $-0.69 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Diversified Healthcare Trust stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 72% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Diversified Healthcare Trust pay a dividend?
Yes. The dividend yield is about 0.54%, and it has paid dividends for 10 years in our data.
Is Diversified Healthcare Trust a good stock to buy?
We do not give buy or sell advice. Diversified Healthcare Trust scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.